vimarsana.com
Home
Live Updates
HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US : comparemela.com
HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US
/PRNewswire/ -- Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, and a subsidiary of Nobelpharma Co.,...
Related Keywords
Maryland ,
United States ,
Japan ,
Tokyo ,
Yoshiki Kida ,
Nobelpharma America ,
Nobelpharma Co Ltd ,
Drug Administration ,
Prnewswire Nobelpharma America ,
Orphan Drug ,
Prescribing Information ,
Facial Angiofibroma Associated ,
Tuberous Sclerosis ,
West Highway ,
comparemela.com © 2020. All Rights Reserved.